A number of authors have shown that high CXCR4 expression levels in infused NK cells was associated with an increased probability of objective response in patients with relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndrome (51). This evidence concerns the gene CXCR4 and myelodysplastic syndrome.